Serán Bioscience

Serán Bioscience, founded in 2008 and headquartered in Bend, Oregon, USA, is a private, revenue-generating CDMO focused on solving complex drug development challenges, particularly bioavailability enhancement for small molecules. The company provides a full suite of services from preformulation and formulation design to clinical and commercial-scale cGMP manufacturing, with a core technological expertise in spray drying and particle engineering. Serán is experiencing accelerated growth, evidenced by the construction of a new 100,000 sq ft commercial manufacturing campus, and positions itself as a flexible, scientifically rigorous partner invested in client success.

Science-driven drug delivery platform specializing in spray drying, particle engineering, and formulation design to enhance bioavailability and develop scalable dosage forms for small molecules.

Serán competes in the fragmented CDMO market, facing competition from large, full-service global CDMOs (e.g., Lonza, Catalent) and other specialized drug delivery/formulation companies. Its differentiation is based on deep scientific expertise in spray drying, a client-centric 'invested partnership' model, and flexibility, but it must continually demonstrate technical superiority and reliability to maintain its position.